HGF and embryonal carcinoma: In line with this observation, in the same paper, we also found that NT2D1 cells, derived from embryonal carcinoma (the lesion from which all non-seminomas originate), increase their malignant behavior in response to HGF administration, whereas TCam-2 seminoma cells do not respond to HGF, at least for the biological responses taken into account in that study.